Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Drug class – FDA Established Pharmacologic Class
This site has the patient information or the package insert of 40 drugs in this class.
Active ingredients in the class
Drugs in the class
- Abacavir Package insert
- Abacavir and Lamivudine Package insert
- Atripla Package insert
- Biktarvy Package insert
- Cimduo Package insert
- Combivir Package insert
- COMPLERA Access Package insert
- Delstrigo Package insert
- Descovy Package insert
- Didanosine Delayed-Release Package insert
- Dovato Package insert
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Package insert
- Efavirenz, Lamivudine, and Tenofovir Disoproxil Package insert
- Emtricitabine Package insert
- Emtricitabine and Tenofovir Disoproxil Package insert
- Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Package insert
- Emtriva Package insert
- Epivir Package insert
- Epivir HBV Package insert
- Epzicom Package insert
- Genvoya Package insert
- Lamivudine Package insert
- Lamivudine and Zidovudine Package insert
- Lamivudine, Zidovudine, and Abacavir Package insert
- Odefsey Package insert
- Retrovir Package insert
- Stavudine Package insert
- Stribild Package insert
- Symfi Package insert
- Symtuza Package insert
- Tenofovir Disoproxil Package insert
- Triumeq Package insert
- Trizivir Package insert
- Truvada Package insert
- Vemlidy Package insert
- Viread Package insert
- Zerit Package insert
- Ziagen Solution Package insert
- Ziagen Tablet Package insert
- Zidovudine Package insert
Sources
- Patient information and package inserts: FDA drug labeling, via the National Library of Medicine DailyMed
- Drug class: FDA Established Pharmacologic Class (EPC) of the drug labeling
Ask your doctor or pharmacist which medicine is right for you.